期刊文献+

阿尔茨海默病患者脑脊液细胞因子研究 被引量:4

Study on the level of cytokine in cerebrospinal fluid in patients with Alzheimer's disease
下载PDF
导出
摘要 目的:探讨细胞因子在阿尔茨海默病(AD)发病机制中的意义和临床诊断价值。方法:采用双抗体夹心酶联免疫吸附试验分别对25例患者脑脊液(CSF)白细胞介素1β(IL-1β)、白细胞介素6(IL-6)及肿瘤坏死因子α(TNF-α)水平检测。结果;AD患者CSFIL-1β、IL-6和TNF-α含量均较正常老年人显著为高(P均<0.01)。结论;AD患者CSFIL-1β、IL-6和TNF-α含量较正常老年人显著增高,为AD的慢性免疫炎症机制提供了理论依据。 Objective: To investigate the pathogenesis meaning and clinical diagnosis value of cytokine in Alzheimer's disease (AD) Method:25 patients with Alzheimer's disease were included. Commercial ELISA adsorption test was used to investigate the levels of interleukin-1β ( IL-1 β ) , interleukin-6 ( IL-6 ) and tumor necrosis factor ct(TNF-α) in CSF of the patients. Results:The average CSF level of IL-1β,IL-6 and TNF-α was significantly higher in AD patients than in healthy controls ( P 〈 0.01 ). Conclusion: These results strongly suggested that inflammatory cytokines IL-1β ,IL-6 and TNF-α should be important factors in the neuro- degeneration process associated with AD and the inflammation should significantly contribute to the pathogenesis of AD.
出处 《临床精神医学杂志》 2008年第5期320-321,共2页 Journal of Clinical Psychiatry
关键词 阿尔茨海默病 白细胞介素1Β 白细胞介素6 肿瘤坏死因子-Α Alzheimer's disease interleukin-1β interleukin-6 tumor necrosis factor-α
  • 相关文献

参考文献10

  • 1Gambi F, Reale M, Larlori C, et al. Alzheimer patients treated with an AchE inhibitor show higher IL -4 and lower IL-1 beta levels and expression in peripheral blood mononuclear cells [ J ].J Clin Psychopharmaeol, 2004,24 : 314 -321.
  • 2Rosenberg PB. Clinical aspects of inflammation in Alzheimer' s disease[ J]. Int Rev Psychiatry,2005,17:503- 514.
  • 3McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease :report of the NINCDSADRDA work group under the auspices of department of health and human services task force on Alzheimer' s disease [ J ]. Neurology, 1984,34:939-944.
  • 4Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheime's disease[ J]. Neurobiol Aging,2000,21:383-421.
  • 5Cagnin A, Brooks DJ, Kennedy AM, et al. In-vivo measurement of activated microglia in demetia [ J ]. Lancet,2001,358:461-467.
  • 6王琳,韩杰,张昱.Alzheimer病病人血清与脑脊液白细胞介素-1及肿瘤坏死因子水平检测的研究[J].中华神经科杂志,2002,35(6):339-341. 被引量:20
  • 7吴崇巍,韩杰,王琳,张昱,许晶.Alzheimer病患者血清和脑脊液中IL-6及sIL-6R水平的研究[J].临床神经病学杂志,2002,15(3):163-164. 被引量:1
  • 8Rosenberg PB. Clinical aspects of inflammation in Alzheimer' s disease[ J]. Int Rev Psychiatry,2005,17:503-514.
  • 9Walker DG, Lue LF, Beach TG. Gene expression profiling of amyloid beta pep tide-stimulated human post-mortem brain microglia [ J]. Neurobiol Aging,2001,22:957-966.
  • 10Fagiolo U, Cossarizza A, Scala E, et al. Increased cytokine production in mononuclear cells of healthy elderly people [ J]. Eur J Immunol, 1993,23:2375-2378.

二级参考文献16

  • 1Griffin WS, Sheng JG, Royston MC, et al. Glial-neuronal interactions in Alzheimer's disease: the potential role of a "cytokine cycle"in disease progression. Brain Pathol, 1998, 8: 65-72.
  • 2McGeer EG, McGeer PL. The importance of inflammatory mechanisms in Alzheimer's disease. Exp Gerontol, 1998, 33: 371-378.
  • 3American Psychiatric Association. DSM-IV: diagnostic and statistical manual of mental disorders 4th ed. Washington: American Psychiatric Association, 1994.92-94.
  • 4McGeer PL, Rogers J, McGeer EG. Neuroimmmune mechanisms in Alzheimer's disease pathogenesis. Alz Dis Assoc Dis, 1994,8:149-158.
  • 5Rothwell NJ, Luheshi GN. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci, 2000, 23: 618-625.
  • 6Sheng JG, Griffin WS, Royston MC, et al. Distribution of interleukin-1 immunoreactive microglia in cerebral cortical layers: implication for neuritic plaque formation in Alzheimer's disease. Neuropathol Appl Neurobiol, 1998, 24: 278-283.
  • 7Griffin WS, Sheng JG, Roberts GW, et al. IL-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol, 1995, 54: 276-281.
  • 8Alvarez XA, Franco A, Fernandez N, et al. Blood levels of histamine, IL-1 β and TNF-α in patients with mild to moderate Alzheimer's disease. Mol Chem Neuropathol, 1996, 29: 237-252.
  • 9Licastro F, Pedrini S, Ludovica C, et al. Increased plasma levels of interleukin-1, interleukin-6 and α1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J Neuroimmunol, 2000, 103: 97-102.
  • 10Dickson DW, Lee SC, Mattiace LA, et al. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia, 1993, 7: 75-83.

共引文献19

同被引文献20

引证文献4

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部